Serum cystatin C, monocyte/high-density lipoprotein-C ratio, and uric acid for the diagnosis of coronary heart disease and heart failure

Table 1 Baseline characteristics of the 80 patients, n (%)

Variable	Total (n = 80)	CHD (n = 20)	HF (n = 20)	CHD + HF (n = 20)	Control (n = 20)	P value
Age (yr)	63.2 ± 9.8	64.1 ± 10.4	62.3 ± 9.6	63.5 ± 9.2	62.9 ± 9.9	0.87
Male	45 (56.3)	12 (60.0)	11 (55.0)	13 (65.0)	9 (45.0)	0.54
Hypertension	52 (65.0)	14 (70.0)	13 (65.0)	15 (75.0)	10 (50.0)	0.23
Diabetes	32 (40.0)	9 (45.0)	8 (40.0)	10 (50.0)	5 (25.0)	0.28
Dyslipidemia	30 (37.5)	8 (40.0)	7 (35.0)	9 (45.0)	6 (30.0)	0.67
Smoking	29 (36.3)	8 (40.0)	7 (35.0)	9 (45.0)	5 (25.0)	0.48
Clinical presentation						0.41
Stable angina	37 (46.3)	10 (50.0)	8 (40.0)	11 (55.0)	8 (40.0)
Unstable angina	27 (33.8)	8 (40.0)	7 (35.0)	8 (40.0)	4 (20.0)
Acute myocardial infarction	16 (20.0)	2 (10.0)	5 (25.0)	1 (5.0)	8 (40.0)
LVEF	55.6 ± 9.2	57.2 ± 8.6	54.1 ± 9.8	53.8 ± 9.4	56.9 ± 8.9	0.59

LVEF: Left ventricular ejection fraction; HF: Heart failure; CHD: Coronary heart disease.